# DYNAVAX TECHNOLOGIES CORP

DYNAVAX TECHNOLOGIES CORP is a company headquartered in Emeryville, CA, United States.

## Company overview

- **Legal name:** DYNAVAX TECHNOLOGIES CORP
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Emeryville, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001029142

## About

DYNAVAX TECHNOLOGIES CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001029142, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-02-20, it reported annual revenue of USD 277,246,000; net income of USD 27,309,000; total assets of USD 986,256,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $277.2M (USD 277,246,000)
- **Net income:** $27.3M (USD 27,309,000)
- **Total assets:** $986.3M (USD 986,256,000)
- **Cash and equivalents:** $95.9M (USD 95,883,000)
- **Operating cash flow:** $66.5M (USD 66,512,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $232.3M (USD 232,284,000)
- **Net income:** -$6.4M (USD -6,389,000)
- **Total assets:** $997.1M (USD 997,096,000)
- **Cash and equivalents:** $150.3M (USD 150,279,000)
- **Operating cash flow:** $100.6M (USD 100,563,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $722.7M (USD 722,683,000)
- **Net income:** $293.2M (USD 293,156,000)
- **Total assets:** $985.9M (USD 985,850,000)
- **Cash and equivalents:** $202.0M (USD 202,004,000)
- **Operating cash flow:** $62.7M (USD 62,716,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $439.4M (USD 439,442,000)
- **Net income:** $76.7M (USD 76,713,000)
- **Total assets:** $1.0B (USD 1,039,246,000)
- **Cash and equivalents:** $436.2M (USD 436,189,000)
- **Operating cash flow:** $335.5M (USD 335,528,000)

## Recent SEC filings

- Form 8-K — filed 2026-02-10 — period 2026-02-10 — 8-K
- Form 8-K — filed 2025-12-29 — period 2025-12-23 — 8-K
- Form 10-Q — filed 2025-11-05 — period 2025-09-30 — 10-Q
- Form 8-K — filed 2025-11-05 — period 2025-11-05 — 8-K
- Form 8-K — filed 2025-10-16 — period 2025-10-15 — 8-K
- Form 8-K — filed 2025-08-21 — period 2025-08-21 — 8-K
- Form 10-Q — filed 2025-08-07 — period 2025-06-30 — 10-Q
- Form 8-K — filed 2025-08-07 — period 2025-08-07 — 8-K
- Form 8-K — filed 2025-06-17 — period 2025-06-11 — 8-K
- Form 8-K — filed 2025-05-13 — period 2025-05-08 — 8-K
- Form 10-Q — filed 2025-05-06 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-06 — period 2025-05-06 — 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/dynavax-technologies-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology
